When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Catalyst Pharma down 13% on adverse ruling in FDA lawsuit
Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals (CPRX-12.7%) is under pressure on 77% higher volume in reaction to an adverse development in its lawsuit against the FDA related to Firdapse (amifampridine phosphate), approved in the U.S. in November 2018 for adults with an autoimmune disorder called Lambert-Eaton syndrome (LEMS), an Orphan Drug-tagged indication which is supposed to provide a seven-year period of market exclusivity.
More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,